ä ä.ä ä

Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !> A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.mmm.2020.11.002

http://scihub22266oqcxt.onion/10.1016/j.mmm.2020.11.002

C7676311/?report=reader!7676311!C7676311
    free
    free
    free

Nephropedia Template TP
{{tp|p=C7676311|t=ä. Prise en charge par t�l�consultation des patients diab�tiques dans le contexte de la pand�mie de la COVID-19�: �tude prospective observationnelle |pdf=|usr=}}
gab.com Text
Prise en charge par t�l�consultation des patients diab�tiques dans le contexte de la pand�mie de la COVID-19�: �tude prospective observationnelle JO: ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=C7676311 #FOAvip The COVID-19 pandemic has compelled the French government to impose confinement measures to stem the spread of the coronavirus. These measures may have had a potential impact on the glycemic control of diabetic patients. Within this context, telemedicine appears to be a viable option for follow-up appointments of diabetic patients. To assess this theory, we simultaneously led a prospective observational study during the novel coronavirus pandemic at Strasbourg's teaching hospital and at a private medical office to evaluate glycemic control in 491 diabetic patients either attending a telehealth appointment (n�=�338) or whom in-person consultation had been postponed by 6 months (n�=�153). Surveys were collected to assess both the patients? and the physicians? satisfaction. A decrease in average glycated hemoglobin (HbA1c) was observed among patients from the telehealth appointment group: ?HbA1c�=�?0.33% (n�=�175) as well as the other group: ?HbA1c�=�?0.13% (n�=�92) 3 months after the beginning of the study. Patients belonging to the telehealth appointment group at Strasbourg's teaching hospital (n�=�97) experienced a decrease in their HbA1c average from 7.65��1.19% to 7.18��0.9%, while patients from the same group attending a private medical office (n�=�78) also experienced a decrease from 7.28��0.80% to 7.11��0.79%. Ninety-two percent of patients were satisfied with the telehealth appointment, think it could be a virtual alternative to in-person consultation and would recommend it to other diabetic patients. Even though seven out of eight diabetologists had never offered telehealth appointments to their patients prior to the COVID-19 pandemic, all of them hope to provide such services to their patients once the health crisis is over. The tendency towards a decrease in HbA1c levels within our cohort should be qualified due to missing data caused by the disruption in data collection during the COVID-19 pandemic. Evaluation and assessment of the cohort's glycemic control 6 months after the beginning of the study could help confirm these results.
Twit Text FOAVip
Prise en charge par t�l�consultation des patients diab�tiques dans le contexte de la pand�mie de la COVID-19�: �tude prospective observationnelle 🦆🦆ä-/-ä http://www.kidney.de/pget.php?&tw=1&pmid=C7676311 #FOAvip
Twit Text #
Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=C7676311 #FOAvip
English Wikipedia
<ref>{{Cite pmid|C7676311}}</ref>

Prise en charge par t�l�consultation des patients diab�tiques dans le contexte de la pand�mie de la COVID-19�: �tude prospective observationnelle #MMPMIDC7676311
Flocard M; Meyer L; Fabacher T; Bahougne T; Ort�ga F; Paris D; Munch M; Boullu-Sanchis S; Canel C; Chappaz C; Kessler L
ä-/-ä ä[]; ä (ä): ä PMIDC7676311show ga
The COVID-19 pandemic has compelled the French government to impose confinement measures to stem the spread of the coronavirus. These measures may have had a potential impact on the glycemic control of diabetic patients. Within this context, telemedicine appears to be a viable option for follow-up appointments of diabetic patients. To assess this theory, we simultaneously led a prospective observational study during the novel coronavirus pandemic at Strasbourg's teaching hospital and at a private medical office to evaluate glycemic control in 491 diabetic patients either attending a telehealth appointment (n�=�338) or whom in-person consultation had been postponed by 6 months (n�=�153). Surveys were collected to assess both the patients? and the physicians? satisfaction. A decrease in average glycated hemoglobin (HbA1c) was observed among patients from the telehealth appointment group: ?HbA1c�=�?0.33% (n�=�175) as well as the other group: ?HbA1c�=�?0.13% (n�=�92) 3 months after the beginning of the study. Patients belonging to the telehealth appointment group at Strasbourg's teaching hospital (n�=�97) experienced a decrease in their HbA1c average from 7.65��1.19% to 7.18��0.9%, while patients from the same group attending a private medical office (n�=�78) also experienced a decrease from 7.28��0.80% to 7.11��0.79%. Ninety-two percent of patients were satisfied with the telehealth appointment, think it could be a virtual alternative to in-person consultation and would recommend it to other diabetic patients. Even though seven out of eight diabetologists had never offered telehealth appointments to their patients prior to the COVID-19 pandemic, all of them hope to provide such services to their patients once the health crisis is over. The tendency towards a decrease in HbA1c levels within our cohort should be qualified due to missing data caused by the disruption in data collection during the COVID-19 pandemic. Evaluation and assessment of the cohort's glycemic control 6 months after the beginning of the study could help confirm these results.
äPrise en charge par t�l�consultation des patients diab�tiques dans le (epmc).pdf

DeepDyve
Pubget Overpricing

ä ä.ä ä